Pethidine and skin warming to prevent shivering during endovascular cooling

Anaesth Intensive Care. 2004 Jun;32(3):362-7. doi: 10.1177/0310057X0403200310.

Abstract

We tested the efficacy of pethidine and cutaneous warming to prevent shivering during percutaneous cooling in unanaesthetized patients. Ten patients scheduled for cranial neurosurgery received pethidine infusion and skin warming. The Setpoint internal heat-exchanging catheter was inserted and cooling to 33.5 degrees C was started. Clonidine and chlorpromazine were given as "rescue medication" to treat shivering. General anaesthesia was planned to be induced after cooling was complete. Rewarming was initiated at dural closure. Three patients successfully completed the protocol, cooling to 33.8 degrees C at a median rate of 3.6 (range: 3.4-3.8) degrees C/h. Two patients cooled to 33.8 degrees C but required treatment for shivering (cooling rate: 2.9 [2.8-3.1] degrees C/h). Four patients failed to cool adequately because of refractory shivering (cooling rate: 20 [1.5-2.9] degrees C/h). One patient did not shiver and yet failed to cool adequately (cooling rate: 0.76 degrees C/h). Rewarming was at a rate of 26 (1.2-4.3) degrees C/h. There were no significant complications arising from catheter placement. The combination of skin warming and pethidine was not reliable enough to be recommended for use during endovascular cooling in unanaesthetized patients.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Body Temperature
  • Brain / surgery
  • Female
  • Heating / methods*
  • Humans
  • Hypothermia, Induced* / methods
  • Infusions, Intravenous
  • Male
  • Meperidine / administration & dosage*
  • Middle Aged
  • Monitoring, Intraoperative
  • Pilot Projects
  • Receptors, Opioid, mu / agonists*
  • Rewarming
  • Shivering*
  • Skin Temperature*

Substances

  • Receptors, Opioid, mu
  • Meperidine